Recce Pharmaceuticals doses all patients in phase II skin infection trial

Recce Pharmaceuticals doses all patients in phase II skin infection trial

Recce Pharmaceuticals doses all patients in Phase 2 clinical trial of RECCE® 327 topical gel for skin infections

Recce Pharmaceuticals doses all patients in Phase 2 clinical trial of RECCE® 327 topical gel for skin infections

Recce gets Indonesian nod for phase III trial of diabetic foot infection treatment

Recce gets Indonesian nod for phase III trial of diabetic foot infection treatment

Complete patent protection for 2 Recce anti-infective treatments

Complete patent protection for 2 Recce anti-infective treatments

Recce green lit to begin dosing in registrational Phase 3 trial for diabetic foot infections

Recce green lit to begin dosing in registrational Phase 3 trial for diabetic foot infections

From No More Tears to no more superbug fears

From No More Tears to no more superbug fears

Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead!

Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead!

Local Pharma Fights Superbugs

Local Pharma Fights Superbugs

Recce’s Phase 2 trial for skin infections hits midway recruitment milestone

Recce’s Phase 2 trial for skin infections hits midway recruitment milestone

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger